Brain tumors: Current issues in diagnosis and management

被引:5
作者
Lyons, Mark K.
Vora, Sujay A.
机构
[1] Mayo Clin, Dept Radiat Oncol, Phoenix, AZ 85054 USA
[2] Mayo Clin, Dept Neurol Surg, Phoenix, AZ 85054 USA
关键词
meningioma; glioma; brain tumor; diagnosis and treatment;
D O I
10.1055/s-2007-985333
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
There has been significant progress made in the diagnosis and treatment of brain tumors over the past 15 years. This has largely been due to significant advances in radiographic imaging capabilities that have allowed for much earlier detection of disease, both new and recurrent. Advances in surgical and radiotherapy techniques and technology have also affected the care of these patients. More recent advances in chemotherapy options and double and triple crossover clinical trials are beginning to have an impact in the treatment of malignant brain tumors. This article will address the 4 most common brain tumors practicing physicians see and will review the current concepts in treating these tumors.
引用
收藏
页码:312 / 324
页数:13
相关论文
共 140 条
  • [11] Epidemiology and etiology of intracranial meningiomas: A review
    Bondy, M
    Ligon, BL
    [J]. JOURNAL OF NEURO-ONCOLOGY, 1996, 29 (03) : 197 - 205
  • [12] Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas
    Brada, M
    Viviers, L
    Abson, C
    Hines, F
    Britton, J
    Ashley, S
    Sardell, S
    Traish, D
    Gonsalves, A
    Wilkins, P
    Westbury, C
    [J]. ANNALS OF ONCOLOGY, 2003, 14 (12) : 1715 - 1721
  • [13] History of allergies and autoimmune diseases and risk of brain tumors in adults
    Brenner, AV
    Linet, MS
    Fine, HA
    Shapiro, WR
    Selker, RG
    Black, PM
    Inskip, PD
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2002, 99 (02) : 252 - 259
  • [14] Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: Efficacy and associations with chromosomal abnormalities
    Buckner, JC
    Gesme, D
    O'Fallon, JR
    Hammock, JE
    Stafford, S
    Brown, PD
    Hawkins, R
    Scheithauer, BW
    Erickson, BJ
    Levitt, R
    Shaw, EG
    Jenkins, R
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (02) : 251 - 255
  • [15] GENETIC SUSCEPTIBILITY TO RADIATION AND CHEMOTHERAPY INJURY - DIAGNOSIS AND MANAGEMENT
    BUSCH, D
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1994, 30 (04): : 997 - 1002
  • [16] SUCCESSFUL CHEMOTHERAPY FOR RECURRENT MALIGNANT OLIGODENDROGLIOMA
    CAIRNCROSS, JG
    MACDONALD, DR
    [J]. ANNALS OF NEUROLOGY, 1988, 23 (04) : 360 - 364
  • [17] Expression of estrogen receptors alpha and beta in human meningiomas
    Carroll, RS
    Zhang, J
    Black, PM
    [J]. JOURNAL OF NEURO-ONCOLOGY, 1999, 42 (02) : 109 - 116
  • [18] Low-grade gliomas: an update on pathology and therapy
    Cavaliere, R
    Lopes, MBS
    Schiff, D
    [J]. LANCET NEUROLOGY, 2005, 4 (11) : 760 - 770
  • [19] Impact of chromosome 1p status in response of oligodendroglioma to temozolomide: preliminary results
    Chahlavi, A
    Kanner, A
    Peereboom, D
    Staugaitis, SM
    Elson, P
    Barnett, G
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2003, 61 (03) : 267 - 273
  • [20] Expression of androgen receptor in meningiomas
    Chen, Jian
    Chen, Gang
    [J]. CURRENT MEDICAL SCIENCE, 2001, 21 (02) : 140 - 142